Report Detail
Global Nuclear Medicine/Radiopharmaceuticals Market Insights, Forecast to 2025
- RnM2851015 |
- 01 February, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.
The global Nuclear Medicine/Radiopharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine/Radiopharmaceuticals market based on company, product type, end user and key regions.
This report studies the global market size of Nuclear Medicine/Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Medicine/Radiopharmaceuticals in these regions.
This research report categorizes the global Nuclear Medicine/Radiopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Nuclear Medicine/Radiopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Market size by Product
Diagnostic
Therapeutic
Market size by End User
Oncology
Thyroid
Cardiology
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Nuclear Medicine/Radiopharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Nuclear Medicine/Radiopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nuclear Medicine/Radiopharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Nuclear Medicine/Radiopharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine/Radiopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Nuclear Medicine/Radiopharmaceuticals Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Product
- 1.4.2 Diagnostic
- 1.4.3 Therapeutic
- 1.5 Market by End User
- 1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Thyroid
- 1.5.4 Cardiology
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size
- 2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue 2014-2025
- 2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales 2014-2025
- 2.2 Nuclear Medicine/Radiopharmaceuticals Growth Rate by Regions
- 2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions
- 2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers
- 3.1.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers
- 3.1.2 Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturers
- 3.1.3 Global Nuclear Medicine/Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
- 3.2 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers
- 3.2.1 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
- 3.3 Nuclear Medicine/Radiopharmaceuticals Price by Manufacturers
- 3.4 Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Product
- 4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Product
- 4.3 Nuclear Medicine/Radiopharmaceuticals Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Nuclear Medicine/Radiopharmaceuticals Breakdown Data by End User
6 North America
- 6.1 North America Nuclear Medicine/Radiopharmaceuticals by Countries
- 6.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries
- 6.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Nuclear Medicine/Radiopharmaceuticals by Product
- 6.3 North America Nuclear Medicine/Radiopharmaceuticals by End User
7 Europe
- 7.1 Europe Nuclear Medicine/Radiopharmaceuticals by Countries
- 7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries
- 7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Nuclear Medicine/Radiopharmaceuticals by Product
- 7.3 Europe Nuclear Medicine/Radiopharmaceuticals by End User
8 Asia Pacific
- 8.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Countries
- 8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries
- 8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Product
- 8.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by End User
9 Central & South America
- 9.1 Central & South America Nuclear Medicine/Radiopharmaceuticals by Countries
- 9.1.1 Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries
- 9.1.2 Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Nuclear Medicine/Radiopharmaceuticals by Product
- 9.3 Central & South America Nuclear Medicine/Radiopharmaceuticals by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Countries
- 10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries
- 10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Product
- 10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by End User
11 Company Profiles
- 11.1 China Isotope & Radiation
- 11.1.1 China Isotope & Radiation Company Details
- 11.1.2 Company Business Overview
- 11.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products Offered
- 11.1.5 China Isotope & Radiation Recent Development
- 11.2 Dongcheng
- 11.2.1 Dongcheng Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Products Offered
- 11.2.5 Dongcheng Recent Development
- 11.3 Jaco
- 11.3.1 Jaco Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Products Offered
- 11.3.5 Jaco Recent Development
- 11.4 Ciaeriar
- 11.4.1 Ciaeriar Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Products Offered
- 11.4.5 Ciaeriar Recent Development
- 11.5 Advanced Molecular-imaging Solution
- 11.5.1 Advanced Molecular-imaging Solution Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Products Offered
- 11.5.5 Advanced Molecular-imaging Solution Recent Development
- 11.6 Shanghai Atom Kexing
- 11.6.1 Shanghai Atom Kexing Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Products Offered
- 11.6.5 Shanghai Atom Kexing Recent Development
12 Future Forecast
- 12.1 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Regions
- 12.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions 2019-2025
- 12.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions 2019-2025
- 12.2 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Product
- 12.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Product 2019-2025
- 12.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Product 2019-2025
- 12.3 Nuclear Medicine/Radiopharmaceuticals Market Forecast by End User
- 12.4 North America Nuclear Medicine/Radiopharmaceuticals Forecast
- 12.5 Europe Nuclear Medicine/Radiopharmaceuticals Forecast
- 12.6 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Forecast
- 12.7 Central & South America Nuclear Medicine/Radiopharmaceuticals Forecast
- 12.8 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Nuclear Medicine/Radiopharmaceuticals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Nuclear Medicine/Radiopharmaceuticals . Industry analysis & Market Report on Nuclear Medicine/Radiopharmaceuticals is a syndicated market report, published as Global Nuclear Medicine/Radiopharmaceuticals Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Nuclear Medicine/Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
